Results per Page:
How can you use a math major to forward science?
Fred Hutch receives continued funding for SeattleStatGROWS supporting undergraduates in statistics and data science research
When it comes to cancer trials, what’s the (end)point?
New endpoint in multiple myeloma could mean faster drug approvals. Are more endpoint tweaks on the way?
The response is what counts
From the Othus Group, Public Health Sciences Division
Othus joins Hutchinson Center biostatisticians
Harvard graduate applies analytic skills to clinical trials